Yuanfang Tang, Mengya Zhong, Guangchao Pan, Jinshui Tan, Chendi Xie, Yuelong Jiang, . . . Jie Zha. (2022). Preclinical Studies of Chiauranib Show It Inhibits Transformed Follicular Lymphoma through the VEGFR2/ERK/STAT3 Signaling Pathway. MDPI AG.
Chicago Style (17th ed.) CitationYuanfang Tang, et al. Preclinical Studies of Chiauranib Show It Inhibits Transformed Follicular Lymphoma Through the VEGFR2/ERK/STAT3 Signaling Pathway. MDPI AG, 2022.
MLA (9th ed.) CitationYuanfang Tang, et al. Preclinical Studies of Chiauranib Show It Inhibits Transformed Follicular Lymphoma Through the VEGFR2/ERK/STAT3 Signaling Pathway. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.